Institut De Recherches Internationales Servier

This study aimed to find the right dose and check the safety of a drug called calaspargase pegol for adults aged 22 and older with a specific type of newly diagnosed acute lymphoblastic leukemia (ALL). The trial was designed in two parts, first confirming the dose and then treati…

This study aimed to understand how an experimental cancer drug travels through the body and how much of it reaches tumors. It used special PET scans to track a tiny radioactive tag attached to the drug in a small group of patients with advanced solid tumors. The main goal was to …